🔺30 Most Innovative Companies to Watch 2024
Tempus Advances Precision Medicine with AI and Extensive Data Insights
At its core, the company seeks to transform healthcare by facilitating personalized treatment options and targeted therapies.

Eric Lefkofsky, Founder & CEO, Tempus
Tempus is at the forefront of advancing precision medicine through the strategic application of AI in healthcare. By harnessing insights from a vast repository of clinical and molecular data, the company is revolutionizing how physicians approach patient care. Tempus provides healthcare professionals with a sophisticated analytical platform powered by machine learning, enabling them to make informed decisions in real-time, tailored to each patient's unique needs.
At its core, Tempus seeks to transform healthcare by facilitating personalized treatment options and targeted therapies. Through collaborative efforts with industry partners, the company aims to streamline the entire process of discovering, developing, and delivering optimized therapeutic solutions. This holistic approach is designed to enhance patient outcomes and address critical medical challenges with innovative and effective strategies.
Tempus operates with a clear and compelling mission: to continually improve patient treatments by leveraging accumulated data for ongoing learning and refinement. The company's commitment to innovation is evident in its development of transformative tools that evolve alongside the expanding datasets they analyze. This dedication is encapsulated in Tempus's guiding principle: “It’s About Time.”
By integrating AI into healthcare practices, Tempus empowers medical professionals to unlock deeper insights into disease mechanisms, treatment responses, and patient outcomes. This data-driven approach not only enhances clinical decision-making but also paves the way for more personalized and effective care strategies. Tempus's analytical capabilities enable physicians to navigate complex medical data swiftly and effectively, thereby optimizing treatment plans and improving patient quality of life.
In collaboration with its partners, Tempus plays a pivotal role in accelerating the pace of medical discovery and therapeutic innovation. By fostering a collaborative ecosystem, the company facilitates the exchange of knowledge, expertise, and resources necessary to advance healthcare solutions. This collaborative model supports the rapid translation of scientific insights into tangible clinical benefits, ultimately benefiting patients worldwide.
The impact of Tempus's work extends beyond individual patient care to encompass broader implications for healthcare systems and medical research. By aggregating and analyzing diverse datasets, the company contributes valuable insights that inform new avenues of research and development. These insights not only drive continuous improvement in treatment protocols but also inspire novel approaches to disease prevention and management.
Tempus's commitment to advancing precision medicine is underscored by its proactive engagement in shaping the future of healthcare. Through strategic initiatives and partnerships, the company strives to democratize access to cutting-edge technologies and data-driven solutions. By making these innovations widely accessible, Tempus aims to empower healthcare providers globally to deliver more effective, personalized care to their patients.
In pursuit of its mission, Tempus remains dedicated to ethical and responsible use of AI and data analytics in healthcare. The company adheres to stringent standards of data privacy and security, ensuring that patient information is protected and used responsibly to drive positive health outcomes. Tempus's ethical framework guides its decision-making processes, ensuring transparency and accountability in all aspects of its operations.
As Tempus continues to pioneer advancements in precision medicine, the company remains committed to fostering a culture of innovation and collaboration. By nurturing talent and expertise within its workforce, Tempus cultivates a dynamic environment where ideas flourish and breakthroughs are achieved. This culture of innovation fuels the company's ongoing quest to push the boundaries of what is possible in healthcare.
Looking forward, Tempus is poised to further expand its impact on precision medicine through continued research, development, and strategic partnerships. By leveraging AI and data-driven insights, the company is well-positioned to drive meaningful improvements in patient care outcomes and contribute to the advancement of global healthcare practices. Tempus's unwavering commitment to its mission ensures that it will remain a driving force in shaping the future of healthcare innovation for years to come.
Put simply, Tempus stands as a beacon of innovation in the field of precision medicine, leveraging AI and data analytics to revolutionize healthcare delivery. Through its collaborative approach, the company is paving the way for personalized treatment solutions and transformative advancements in medical research. With a steadfast commitment to continuous learning and improvement, Tempus is poised to redefine the standard of care and improve patient outcomes worldwide.
Eric Lefkofsky: Founder & CEO
Eric Lefkofsky is the founder and CEO at Tempus, a leader in artificial intelligence and precision medicine. He is the co-founder and General Partner of Lightbank, a private venture capital firm specializing in investments in technology companies. He is also the co-founder of Pathos AI, a clinical stage biotechnology company focused on re-engineering drug development; Groupon (NASDAQ: GRPN), a global e-commerce marketplace; Mediaocean, a leading provider of integrated media procurement technology; Echo Global Logistics (NASDAQ: ECHO), a technology-enabled transportation and logistics outsourcing firm; and InnerWorkings (NASDAQ: INWK), a global provider of managed print and promotional solutions.
He co-chairs the Lefkofsky Family Foundation with his wife Liz to advance high-impact initiatives that enhance lives in the communities served. Lefkofsky also serves on the board of directors of Northwestern Medicine. He holds a bachelor’s degree from the University of Michigan and a J.D. from the University of Michigan Law School.
By integrating AI into healthcare practices, Tempus empowers medical professionals to unlock deeper insights into disease mechanisms, treatment responses, and patient outcomes.